CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +47,250 | 47,250 | ||
| 2021-03-04 | SCHEINBERG DAVID A Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-03-04 | Varian John Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-03-04 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-03-04 | VAN NOSTRAND ROBERT L Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-03-04 | Burns John Thomas VP, Finance & Corp Controller | Grant or award | +2,875 | 12,875 | ||
| 2021-03-04 | Burns John Thomas VP, Finance & Corp Controller | Grant or award · Stock Option (Right to Buy) | +17,250 | 17,250 | ||
| 2021-03-04 | Stergiou Angelos M. President and CEO | Grant or award | +19,750 | 98,287 | ||
| 2021-03-04 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +118,500 | 118,500 | ||
| 2020-03-12 | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | Grant or award | +35,000 | 35,000 | ||
| 2020-03-12 | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-03-12 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2020-03-12 | Varian John Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2020-03-12 | VAN NOSTRAND ROBERT L Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2020-03-12 | Stergiou Angelos M. President and CEO | Grant or award | +95,000 | 95,000 | ||
| 2020-03-12 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2020-03-12 | SCHEINBERG DAVID A Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2020-03-12 | Burns John Thomas VP, Finance & Corp Controller | Grant or award | +15,000 | 15,000 | ||
| 2020-03-12 | Burns John Thomas VP, Finance & Corp Controller | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-03-14 | SCHEINBERG DAVID A Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 6 of 8 · 141 trades